(Q45396552)

14 December 2017

Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats (English)

1 reference

14 December 2017

1 reference

1 reference

Young Sun Kang

1

1 reference

14 December 2017

Gang Jee Ko

2

1 reference

14 December 2017

Mi Hwa Lee

3

1 reference

14 December 2017

Hye Kyoung Song

4

1 reference

14 December 2017

Sang Youb Han

5

1 reference

14 December 2017

Kum Hyun Han

6

1 reference

14 December 2017

Hyoung Kyu Kim

7

1 reference

14 December 2017

Jee Young Han

8

1 reference

14 December 2017

Dae Ryong Cha

9

1 reference

14 December 2017

language of work or name

English

0 references

publication date

5 August 2008

1 reference

Nephrology Dialysis Transplantation

14 December 2017

1 reference

14 December 2017

24

1 reference

14 December 2017

1

1 reference

14 December 2017

73-84

1 reference

Renin-angiotensin system and cardiovascular risk

14 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN448

Strategies to achieve coronary arterial plaque stabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN448

Role of reactive oxygen species in angiotensin II-mediated renal growth, differentiation, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN448

The renin-angiotensin system and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN448

Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN448

Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN448

Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN448

Spironolactone and angiotensin receptor blocker in nondiabetic renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN448

Effectiveness of aldosterone blockade in patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN448

Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in L-NAME/SHR model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN448

Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN448

Beneficial impact of spironolactone in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN448

Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN448

Combination therapy with aldosterone blockade and renin-angiotensin inhibitors confers organ protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN448

The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN448

Effect of aldosterone on renal transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN448

The effect of spironolactone on circulating adipocytokines in patients with type 2 diabetes mellitus complicated by diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN448

Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN448

Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN448

21 January 2018

Identifiers

DOI

10.1093/NDT/GFN448

1 reference

14 December 2017

1 reference